No Picture
News

Regel Therapeutics details its proprietary T3 platform and development pipeline on its newly launched website, expands its Board of Directors and announces its Scientific Advisory Board.

The company launches its website with key pipeline information Regel adds industry leader Andrew Schiermeier, Ph.D to its Board of Directors Regel announces its Scientific Advisory Board chaired by Regel Co-Founder Orrin Devinsky, M.D. CAMBRIDGE, Mass…. […]

No Picture
News

fuseproject Expands Internationally with the Launch of fusedigital, an All New Agency Division Dedicated to Delivering Innovative, Digital-first Experiences

The news follows fuseproject’s acquisition of Mindshaker, a Lisbon-based digital design agency SAN FRANCISCO, Jan. 27, 2023 /PRNewswire/ — fuseproject, the industry-leading multidisciplinary design studio founded in 1999 by award-winning innovator, Yv… […]

No Picture
News

Glaucoma Research Foundation Hosts 12th Annual Glaucoma 360 New Horizons Forum in San Francisco

SAN FRANCISCO, Jan. 27, 2023 /PRNewswire/ — Glaucoma Research Foundation (GRF) will host the 12th Annual Glaucoma 360 New Horizons Forum on February 3rd at San Francisco’s iconic Westin St. Francis Hotel. Attracting nearly 400 participants annually, t… […]